Structure

Physi-Chem Properties

Molecular Weight:  494.3
Volume:  536.002
LogP:  4.597
LogD:  3.482
LogS:  -4.687
# Rotatable Bonds:  9
TPSA:  80.67
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.304
Synthetic Accessibility Score:  5.202
Fsp3:  0.645
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.239
MDCK Permeability:  2.5882334739435464e-05
Pgp-inhibitor:  0.184
Pgp-substrate:  0.009
Human Intestinal Absorption (HIA):  0.05
20% Bioavailability (F20%):  0.482
30% Bioavailability (F30%):  0.618

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.9
Plasma Protein Binding (PPB):  89.94648742675781%
Volume Distribution (VD):  0.37
Pgp-substrate:  11.021533966064453%

ADMET: Metabolism

CYP1A2-inhibitor:  0.011
CYP1A2-substrate:  0.167
CYP2C19-inhibitor:  0.043
CYP2C19-substrate:  0.689
CYP2C9-inhibitor:  0.266
CYP2C9-substrate:  0.054
CYP2D6-inhibitor:  0.013
CYP2D6-substrate:  0.054
CYP3A4-inhibitor:  0.403
CYP3A4-substrate:  0.834

ADMET: Excretion

Clearance (CL):  0.866
Half-life (T1/2):  0.697

ADMET: Toxicity

hERG Blockers:  0.245
Human Hepatotoxicity (H-HT):  0.587
Drug-inuced Liver Injury (DILI):  0.103
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.769
Maximum Recommended Daily Dose:  0.946
Skin Sensitization:  0.956
Carcinogencity:  0.796
Eye Corrosion:  0.027
Eye Irritation:  0.05
Respiratory Toxicity:  0.988

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC171395

Natural Product ID:  NPC171395
Common Name*:   Norselic Acid E
IUPAC Name:   (8R,9S,10R,13S,14S,17R)-17-[(2R,5R)-5-acetyloxy-5-ethyl-6-methylhept-6-en-2-yl]-10-methyl-3-oxo-8,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthrene-13-carboxylic acid
Synonyms:   Norselic Acid E
Standard InCHIKey:  JFWKHVJJUMJZAN-RKDCWTDHSA-N
Standard InCHI:  InChI=1S/C31H42O5/c1-7-30(19(2)3,36-21(5)32)16-12-20(4)25-10-11-27-24-9-8-22-18-23(33)13-15-29(22,6)26(24)14-17-31(25,27)28(34)35/h8-9,13,15,18,20,24-27H,2,7,10-12,14,16-17H2,1,3-6H3,(H,34,35)/t20-,24-,25-,26+,27+,29+,30-,31+/m1/s1
SMILES:  CC[C@@](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C(=O)O)(C(=C)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1221672
PubChem CID:   44557652
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0002031] Stigmastanes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33060 crella sp. Species Crellidae Eukaryota n.a. Antarctic n.a. PMID[19848433]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 3.6 uM PMID[538222]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC171395 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9438 High Similarity NPC204341
0.9 High Similarity NPC262043
0.8778 High Similarity NPC136948
0.8764 High Similarity NPC29447
0.875 High Similarity NPC69279
0.875 High Similarity NPC83569
0.8737 High Similarity NPC476253
0.866 High Similarity NPC99411
0.8602 High Similarity NPC474018
0.8602 High Similarity NPC473986
0.8542 High Similarity NPC202705
0.8539 High Similarity NPC470015
0.8539 High Similarity NPC310470
0.8539 High Similarity NPC168188
0.8523 High Similarity NPC201912
0.8523 High Similarity NPC477372
0.8523 High Similarity NPC38350
0.8515 High Similarity NPC220155
0.8478 Intermediate Similarity NPC72397
0.8454 Intermediate Similarity NPC57079
0.8454 Intermediate Similarity NPC98868
0.8454 Intermediate Similarity NPC166745
0.8454 Intermediate Similarity NPC108368
0.8454 Intermediate Similarity NPC235464
0.8444 Intermediate Similarity NPC87552
0.8444 Intermediate Similarity NPC164577
0.8427 Intermediate Similarity NPC260956
0.8427 Intermediate Similarity NPC320514
0.8416 Intermediate Similarity NPC91034
0.8416 Intermediate Similarity NPC475294
0.84 Intermediate Similarity NPC472868
0.8387 Intermediate Similarity NPC285982
0.8387 Intermediate Similarity NPC173042
0.8387 Intermediate Similarity NPC5509
0.8384 Intermediate Similarity NPC475320
0.8352 Intermediate Similarity NPC94531
0.8352 Intermediate Similarity NPC311702
0.8352 Intermediate Similarity NPC123319
0.835 Intermediate Similarity NPC473627
0.835 Intermediate Similarity NPC37116
0.8333 Intermediate Similarity NPC295347
0.8333 Intermediate Similarity NPC477373
0.8333 Intermediate Similarity NPC97913
0.8333 Intermediate Similarity NPC293052
0.8317 Intermediate Similarity NPC189863
0.8317 Intermediate Similarity NPC266570
0.8316 Intermediate Similarity NPC472871
0.8315 Intermediate Similarity NPC147066
0.8315 Intermediate Similarity NPC278459
0.83 Intermediate Similarity NPC470954
0.8298 Intermediate Similarity NPC472866
0.8298 Intermediate Similarity NPC476369
0.8298 Intermediate Similarity NPC476437
0.8295 Intermediate Similarity NPC477371
0.8295 Intermediate Similarity NPC196827
0.8295 Intermediate Similarity NPC274996
0.828 Intermediate Similarity NPC24816
0.828 Intermediate Similarity NPC472870
0.828 Intermediate Similarity NPC117122
0.8269 Intermediate Similarity NPC474315
0.8261 Intermediate Similarity NPC472869
0.8247 Intermediate Similarity NPC155676
0.8247 Intermediate Similarity NPC472941
0.8247 Intermediate Similarity NPC456
0.8242 Intermediate Similarity NPC472865
0.8229 Intermediate Similarity NPC476415
0.8222 Intermediate Similarity NPC133391
0.8222 Intermediate Similarity NPC3511
0.8222 Intermediate Similarity NPC321289
0.8222 Intermediate Similarity NPC100297
0.8222 Intermediate Similarity NPC327969
0.8222 Intermediate Similarity NPC296367
0.8222 Intermediate Similarity NPC142253
0.82 Intermediate Similarity NPC32577
0.82 Intermediate Similarity NPC155332
0.82 Intermediate Similarity NPC114540
0.8191 Intermediate Similarity NPC36668
0.8191 Intermediate Similarity NPC284561
0.8191 Intermediate Similarity NPC118011
0.8191 Intermediate Similarity NPC474570
0.8191 Intermediate Similarity NPC66344
0.8191 Intermediate Similarity NPC305039
0.8191 Intermediate Similarity NPC177141
0.819 Intermediate Similarity NPC221144
0.819 Intermediate Similarity NPC191620
0.819 Intermediate Similarity NPC236217
0.8182 Intermediate Similarity NPC74410
0.8173 Intermediate Similarity NPC29133
0.8173 Intermediate Similarity NPC16270
0.8172 Intermediate Similarity NPC128644
0.8172 Intermediate Similarity NPC75315
0.8172 Intermediate Similarity NPC477228
0.8172 Intermediate Similarity NPC163016
0.8172 Intermediate Similarity NPC236618
0.8172 Intermediate Similarity NPC136548
0.8163 Intermediate Similarity NPC208094
0.8163 Intermediate Similarity NPC253826
0.8155 Intermediate Similarity NPC472825
0.8152 Intermediate Similarity NPC470048
0.8152 Intermediate Similarity NPC269638
0.8152 Intermediate Similarity NPC474537
0.8152 Intermediate Similarity NPC473038
0.8152 Intermediate Similarity NPC189311
0.8152 Intermediate Similarity NPC11711
0.8152 Intermediate Similarity NPC8571
0.8144 Intermediate Similarity NPC33473
0.8144 Intermediate Similarity NPC20546
0.8144 Intermediate Similarity NPC209355
0.8132 Intermediate Similarity NPC279639
0.8132 Intermediate Similarity NPC474976
0.8132 Intermediate Similarity NPC3856
0.8132 Intermediate Similarity NPC49019
0.8132 Intermediate Similarity NPC474790
0.8131 Intermediate Similarity NPC476963
0.8125 Intermediate Similarity NPC152897
0.8125 Intermediate Similarity NPC66429
0.8119 Intermediate Similarity NPC329345
0.8119 Intermediate Similarity NPC112009
0.8119 Intermediate Similarity NPC180204
0.8119 Intermediate Similarity NPC473283
0.8119 Intermediate Similarity NPC475526
0.8119 Intermediate Similarity NPC72151
0.8105 Intermediate Similarity NPC175628
0.8105 Intermediate Similarity NPC477149
0.8105 Intermediate Similarity NPC477147
0.8105 Intermediate Similarity NPC111585
0.8105 Intermediate Similarity NPC474842
0.8105 Intermediate Similarity NPC129913
0.8105 Intermediate Similarity NPC148414
0.8105 Intermediate Similarity NPC475965
0.81 Intermediate Similarity NPC476240
0.81 Intermediate Similarity NPC168319
0.81 Intermediate Similarity NPC194028
0.81 Intermediate Similarity NPC224720
0.81 Intermediate Similarity NPC310981
0.81 Intermediate Similarity NPC146822
0.81 Intermediate Similarity NPC476223
0.8095 Intermediate Similarity NPC470961
0.8085 Intermediate Similarity NPC472302
0.8081 Intermediate Similarity NPC471717
0.8081 Intermediate Similarity NPC92275
0.8081 Intermediate Similarity NPC197386
0.8077 Intermediate Similarity NPC137911
0.8077 Intermediate Similarity NPC228477
0.8065 Intermediate Similarity NPC186975
0.8065 Intermediate Similarity NPC6247
0.8065 Intermediate Similarity NPC472863
0.8061 Intermediate Similarity NPC250757
0.8061 Intermediate Similarity NPC301534
0.8061 Intermediate Similarity NPC190713
0.8061 Intermediate Similarity NPC328371
0.8043 Intermediate Similarity NPC320801
0.8043 Intermediate Similarity NPC19849
0.8043 Intermediate Similarity NPC209882
0.8043 Intermediate Similarity NPC473246
0.8043 Intermediate Similarity NPC472864
0.8041 Intermediate Similarity NPC56525
0.8041 Intermediate Similarity NPC469406
0.8041 Intermediate Similarity NPC184870
0.8039 Intermediate Similarity NPC473175
0.8037 Intermediate Similarity NPC470953
0.8037 Intermediate Similarity NPC474181
0.8022 Intermediate Similarity NPC193347
0.8022 Intermediate Similarity NPC469805
0.8022 Intermediate Similarity NPC469799
0.8022 Intermediate Similarity NPC469806
0.8022 Intermediate Similarity NPC469804
0.8022 Intermediate Similarity NPC472239
0.8021 Intermediate Similarity NPC26888
0.8021 Intermediate Similarity NPC218301
0.8021 Intermediate Similarity NPC19114
0.8021 Intermediate Similarity NPC470113
0.802 Intermediate Similarity NPC473163
0.802 Intermediate Similarity NPC320447
0.8019 Intermediate Similarity NPC475524
0.8019 Intermediate Similarity NPC100267
0.8 Intermediate Similarity NPC84271
0.8 Intermediate Similarity NPC287833
0.8 Intermediate Similarity NPC54705
0.8 Intermediate Similarity NPC241221
0.8 Intermediate Similarity NPC35751
0.8 Intermediate Similarity NPC476274
0.8 Intermediate Similarity NPC266955
0.8 Intermediate Similarity NPC102414
0.8 Intermediate Similarity NPC474889
0.8 Intermediate Similarity NPC201406
0.8 Intermediate Similarity NPC214387
0.8 Intermediate Similarity NPC174342
0.8 Intermediate Similarity NPC77168
0.8 Intermediate Similarity NPC474844
0.8 Intermediate Similarity NPC227865
0.7981 Intermediate Similarity NPC475418
0.7981 Intermediate Similarity NPC473482
0.7981 Intermediate Similarity NPC318363
0.798 Intermediate Similarity NPC110937
0.798 Intermediate Similarity NPC108078
0.798 Intermediate Similarity NPC141401
0.798 Intermediate Similarity NPC2049
0.798 Intermediate Similarity NPC57416
0.798 Intermediate Similarity NPC107243

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC171395 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8804 High Similarity NPD5284 Approved
0.8804 High Similarity NPD5281 Approved
0.8602 High Similarity NPD6050 Approved
0.8602 High Similarity NPD5694 Approved
0.8495 Intermediate Similarity NPD5692 Phase 3
0.8495 Intermediate Similarity NPD5207 Approved
0.8404 Intermediate Similarity NPD5693 Phase 1
0.8333 Intermediate Similarity NPD5695 Phase 3
0.8261 Intermediate Similarity NPD5690 Phase 2
0.8261 Intermediate Similarity NPD5280 Approved
0.8261 Intermediate Similarity NPD4694 Approved
0.8191 Intermediate Similarity NPD6080 Approved
0.8191 Intermediate Similarity NPD6904 Approved
0.8191 Intermediate Similarity NPD6673 Approved
0.8163 Intermediate Similarity NPD6084 Phase 2
0.8163 Intermediate Similarity NPD6083 Phase 2
0.8085 Intermediate Similarity NPD6672 Approved
0.8085 Intermediate Similarity NPD5737 Approved
0.8022 Intermediate Similarity NPD4221 Approved
0.8022 Intermediate Similarity NPD4223 Phase 3
0.7959 Intermediate Similarity NPD5654 Approved
0.7957 Intermediate Similarity NPD5329 Approved
0.7938 Intermediate Similarity NPD6399 Phase 3
0.79 Intermediate Similarity NPD5696 Approved
0.7895 Intermediate Similarity NPD5208 Approved
0.7872 Intermediate Similarity NPD6098 Approved
0.7872 Intermediate Similarity NPD5279 Phase 3
0.7872 Intermediate Similarity NPD7521 Approved
0.7872 Intermediate Similarity NPD7334 Approved
0.7872 Intermediate Similarity NPD6409 Approved
0.7872 Intermediate Similarity NPD7146 Approved
0.7872 Intermediate Similarity NPD5330 Approved
0.7872 Intermediate Similarity NPD6684 Approved
0.7849 Intermediate Similarity NPD4197 Approved
0.7822 Intermediate Similarity NPD6404 Discontinued
0.7812 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.781 Intermediate Similarity NPD6881 Approved
0.781 Intermediate Similarity NPD6899 Approved
0.78 Intermediate Similarity NPD5959 Approved
0.7778 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7732 Intermediate Similarity NPD4096 Approved
0.7727 Intermediate Similarity NPD5733 Approved
0.7727 Intermediate Similarity NPD7115 Discovery
0.7727 Intermediate Similarity NPD4687 Approved
0.7714 Intermediate Similarity NPD5697 Approved
0.7708 Intermediate Similarity NPD6903 Approved
0.7708 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD4518 Approved
0.7692 Intermediate Similarity NPD4195 Approved
0.7684 Intermediate Similarity NPD5205 Approved
0.7684 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD4688 Approved
0.7684 Intermediate Similarity NPD4693 Phase 3
0.7684 Intermediate Similarity NPD4689 Approved
0.7684 Intermediate Similarity NPD4690 Approved
0.7684 Intermediate Similarity NPD4138 Approved
0.7664 Intermediate Similarity NPD7102 Approved
0.7664 Intermediate Similarity NPD7290 Approved
0.7664 Intermediate Similarity NPD6883 Approved
0.7653 Intermediate Similarity NPD6079 Approved
0.7642 Intermediate Similarity NPD6011 Approved
0.7634 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD4753 Phase 2
0.7619 Intermediate Similarity NPD6675 Approved
0.7619 Intermediate Similarity NPD7128 Approved
0.7619 Intermediate Similarity NPD6402 Approved
0.7619 Intermediate Similarity NPD5739 Approved
0.7604 Intermediate Similarity NPD3573 Approved
0.76 Intermediate Similarity NPD4629 Approved
0.76 Intermediate Similarity NPD5210 Approved
0.7593 Intermediate Similarity NPD6649 Approved
0.7593 Intermediate Similarity NPD8130 Phase 1
0.7593 Intermediate Similarity NPD6847 Approved
0.7593 Intermediate Similarity NPD6650 Approved
0.7593 Intermediate Similarity NPD6617 Approved
0.7593 Intermediate Similarity NPD6869 Approved
0.7576 Intermediate Similarity NPD5133 Approved
0.757 Intermediate Similarity NPD6013 Approved
0.757 Intermediate Similarity NPD6014 Approved
0.757 Intermediate Similarity NPD6012 Approved
0.7549 Intermediate Similarity NPD7638 Approved
0.7528 Intermediate Similarity NPD4058 Approved
0.7523 Intermediate Similarity NPD6882 Approved
0.7523 Intermediate Similarity NPD8297 Approved
0.75 Intermediate Similarity NPD7748 Approved
0.75 Intermediate Similarity NPD4623 Approved
0.75 Intermediate Similarity NPD6001 Approved
0.75 Intermediate Similarity NPD4519 Discontinued
0.75 Intermediate Similarity NPD5276 Approved
0.7477 Intermediate Similarity NPD7320 Approved
0.7476 Intermediate Similarity NPD7640 Approved
0.7476 Intermediate Similarity NPD7639 Approved
0.7474 Intermediate Similarity NPD3666 Approved
0.7474 Intermediate Similarity NPD4786 Approved
0.7474 Intermediate Similarity NPD3665 Phase 1
0.7474 Intermediate Similarity NPD3133 Approved
0.7449 Intermediate Similarity NPD5328 Approved
0.7419 Intermediate Similarity NPD4695 Discontinued
0.7407 Intermediate Similarity NPD6372 Approved
0.7407 Intermediate Similarity NPD6373 Approved
0.7396 Intermediate Similarity NPD1694 Approved
0.7391 Intermediate Similarity NPD3617 Approved
0.7383 Intermediate Similarity NPD5701 Approved
0.7383 Intermediate Similarity NPD6614 Approved
0.7353 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD5222 Approved
0.7353 Intermediate Similarity NPD5221 Approved
0.734 Intermediate Similarity NPD4139 Approved
0.734 Intermediate Similarity NPD4692 Approved
0.7333 Intermediate Similarity NPD5211 Phase 2
0.732 Intermediate Similarity NPD3618 Phase 1
0.7308 Intermediate Similarity NPD4696 Approved
0.7308 Intermediate Similarity NPD5285 Approved
0.7308 Intermediate Similarity NPD5286 Approved
0.73 Intermediate Similarity NPD7515 Phase 2
0.73 Intermediate Similarity NPD6411 Approved
0.7282 Intermediate Similarity NPD5173 Approved
0.7282 Intermediate Similarity NPD7902 Approved
0.7273 Intermediate Similarity NPD6051 Approved
0.7273 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD6052 Approved
0.7263 Intermediate Similarity NPD3667 Approved
0.7238 Intermediate Similarity NPD5223 Approved
0.7228 Intermediate Similarity NPD4202 Approved
0.72 Intermediate Similarity NPD5785 Approved
0.7196 Intermediate Similarity NPD5141 Approved
0.7193 Intermediate Similarity NPD6335 Approved
0.7191 Intermediate Similarity NPD4747 Approved
0.7191 Intermediate Similarity NPD4691 Approved
0.7188 Intermediate Similarity NPD4788 Approved
0.7184 Intermediate Similarity NPD7614 Phase 1
0.717 Intermediate Similarity NPD5225 Approved
0.717 Intermediate Similarity NPD4633 Approved
0.717 Intermediate Similarity NPD5226 Approved
0.717 Intermediate Similarity NPD5091 Approved
0.717 Intermediate Similarity NPD5224 Approved
0.7168 Intermediate Similarity NPD6868 Approved
0.7143 Intermediate Similarity NPD4632 Approved
0.713 Intermediate Similarity NPD7101 Approved
0.713 Intermediate Similarity NPD7100 Approved
0.7115 Intermediate Similarity NPD4755 Approved
0.7105 Intermediate Similarity NPD6317 Approved
0.7103 Intermediate Similarity NPD5174 Approved
0.7103 Intermediate Similarity NPD5175 Approved
0.71 Intermediate Similarity NPD6101 Approved
0.71 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD4137 Phase 3
0.7065 Intermediate Similarity NPD8039 Approved
0.7054 Intermediate Similarity NPD6053 Discontinued
0.7043 Intermediate Similarity NPD6313 Approved
0.7043 Intermediate Similarity NPD6314 Approved
0.7021 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD4697 Phase 3
0.7018 Intermediate Similarity NPD6274 Approved
0.701 Intermediate Similarity NPD3527 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6686 Approved
0.699 Remote Similarity NPD7901 Clinical (unspecified phase)
0.699 Remote Similarity NPD7900 Approved
0.6981 Remote Similarity NPD4700 Approved
0.6972 Remote Similarity NPD6008 Approved
0.6961 Remote Similarity NPD8034 Phase 2
0.6961 Remote Similarity NPD7637 Suspended
0.6961 Remote Similarity NPD8035 Phase 2
0.6957 Remote Similarity NPD4785 Approved
0.6957 Remote Similarity NPD4784 Approved
0.6957 Remote Similarity NPD6009 Approved
0.6939 Remote Similarity NPD3668 Phase 3
0.6923 Remote Similarity NPD6319 Approved
0.6923 Remote Similarity NPD4243 Approved
0.6911 Remote Similarity NPD7260 Phase 2
0.6909 Remote Similarity NPD6412 Phase 2
0.6893 Remote Similarity NPD5779 Approved
0.6893 Remote Similarity NPD5778 Approved
0.6891 Remote Similarity NPD7604 Phase 2
0.6869 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6864 Remote Similarity NPD7503 Approved
0.6864 Remote Similarity NPD5983 Phase 2
0.6864 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6857 Remote Similarity NPD7732 Phase 3
0.6852 Remote Similarity NPD7632 Discontinued
0.6847 Remote Similarity NPD4730 Approved
0.6847 Remote Similarity NPD4729 Approved
0.6833 Remote Similarity NPD7492 Approved
0.6789 Remote Similarity NPD4754 Approved
0.678 Remote Similarity NPD6054 Approved
0.6777 Remote Similarity NPD6616 Approved
0.6777 Remote Similarity NPD6336 Discontinued
0.6762 Remote Similarity NPD1698 Clinical (unspecified phase)
0.675 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6739 Remote Similarity NPD6081 Approved
0.6735 Remote Similarity NPD5209 Approved
0.6729 Remote Similarity NPD4225 Approved
0.6726 Remote Similarity NPD5249 Phase 3
0.6726 Remote Similarity NPD5251 Approved
0.6726 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5247 Approved
0.6726 Remote Similarity NPD5135 Approved
0.6726 Remote Similarity NPD5250 Approved
0.6726 Remote Similarity NPD5169 Approved
0.6726 Remote Similarity NPD5248 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data